Delivery Order SPE2DB20D1100-SPE2DB25FA8D1

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,364.35, is a Firm Fixed Price Delivery Order for the supply of 4567201817 ! ONDANSETRON ODT 8 MG TABLET 30S. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,915.26 Firm Fixed Price Delivery Order is for the supply of 4567089257 - ONDANSETRON ODT 8 MG TABLET 30S, with a completion date of January 30, 2025. The contract is not associated with any set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,487.64, is a delivery order for the supply of 4562924631 - ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of November 29, 2023 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,969.44 firm-fixed-price delivery order supports the procurement of 4566827485 ONDANSETRON HCL 4 MG TABLET 30S, with a period of performance through January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,618.04 firm fixed-price delivery order is for 4566628735 ONDANSETRON HCL 8 MG TABLET 30S, with an ultimate completion date of December 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,306.95 firm fixed-price delivery order covers the supply of 4566565172 ONDANSETRON ODT 8 MG TABLET 30S, with a period of performance through November 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,495.59, is a Firm Fixed Price Delivery Order for the supply of 4567254281 ONDANSETRON HCL 4 MG TABLET 30S. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,973.32, is a delivery order for the provision of 4567052687 ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,566.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of 4564858890 - ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.48, is a Firm Fixed Price Delivery Order for 4566556828 ONDANSETRON ODT 8 MG TABLET 30S. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA8D1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,553.28, is a Firm Fixed Price Delivery Order for the supply of 4567409257 - ONDANSETRON HCL 8 MG TABLET 30S. The contract has an ultimate completion date of February 28, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 6/1/25, 2:56 AM